000 | 01160 a2200313 4500 | ||
---|---|---|---|
005 | 20250517175150.0 | ||
264 | 0 | _c20190509 | |
008 | 201905s 0 0 eng d | ||
022 | _a1876-4479 | ||
024 | 7 |
_a10.1093/ecco-jcc/jjx119 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRoblin, Xavier | |
245 | 0 | 0 |
_aThe End of the Dosage of 6-Thioguanine Nucleotides? Not so Sureā¦. _h[electronic resource] |
260 |
_bJournal of Crohn's & colitis _cJan 2018 |
||
300 |
_a126 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Dosage Calculations |
650 | 0 | 4 |
_aDrug Monitoring _xmethods |
650 | 0 | 4 |
_aGastrointestinal Agents _xadministration & dosage |
650 | 0 | 4 |
_aGuanine Nucleotides _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammatory Bowel Diseases _xblood |
650 | 0 | 4 |
_aRemission Induction _xmethods |
650 | 0 | 4 |
_aThionucleotides _xadministration & dosage |
700 | 1 | _aPaul, Stephane | |
773 | 0 |
_tJournal of Crohn's & colitis _gvol. 12 _gno. 1 _gp. 126 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/ecco-jcc/jjx119 _zAvailable from publisher's website |
999 |
_c27615624 _d27615624 |